Hook, L. M., Awasthi, S., Dubin, J., Flechtner, J., Long, D., & Friedman, H. M. (2018). A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection. Vaccine.

Hook, Lauren M., Sita Awasthi, Jonathan Dubin, Jessica Flechtner, Deborah Long, and Harvey M. Friedman. "A Trivalent GC2/gD2/gE2 Vaccine for Herpes Simplex Virus Generates Antibody Responses That Block Immune Evasion Domains On GC2 Better Than Natural Infection." Vaccine 2018.

Hook, Lauren M., et al. "A Trivalent GC2/gD2/gE2 Vaccine for Herpes Simplex Virus Generates Antibody Responses That Block Immune Evasion Domains On GC2 Better Than Natural Infection." Vaccine 2018.